About Suturegard
Suturegard is a company based in Portland (United States) founded in 2015 by Jen Akeroyd and Bill Lear.. Suturegard has raised $580 thousand across 3 funding rounds. Suturegard operates in a competitive market with competitors including Adhezion Biomedical, Inno Therapy, HyperBranch Medical, BRIJ Medical and Limax Biosciences, among others.
- Headquarter Portland, United States
- Founders Jen Akeroyd, Bill Lear
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Suturegard Medical, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$580 K (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Suturegard
Suturegard has successfully raised a total of $580K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(14 Jan 2021)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Seed - Suturegard | Valuation |
investors |
|
| Apr, 2021 | Amount | Seed - Suturegard | Valuation |
investors |
|
| Jan, 2021 | Amount | Seed - Suturegard | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Suturegard
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Suturegard
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Suturegard Comparisons
Competitors of Suturegard
Suturegard operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adhezion Biomedical, Inno Therapy, HyperBranch Medical, BRIJ Medical and Limax Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cyanoacrylate based surgical, wound management, and infection prevention products
|
|
| domain | founded_year | HQ Location |
Hemostatic polymers are produced for surgical and wound care applications.
|
|
| domain | founded_year | HQ Location |
Biosurgical devices are developed using proprietary polymers and hydrogels.
|
|
| domain | founded_year | HQ Location |
Medical devices for post-surgical and trauma incision care are provided.
|
|
| domain | founded_year | HQ Location |
Stretchable hydrogel adhesives are developed for wound sealing and healing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Suturegard
When was Suturegard founded?
Suturegard was founded in 2015 and raised its 1st funding round 6 years after it was founded.
Where is Suturegard located?
Suturegard is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
Who is the current CEO of Suturegard?
Dan Ladizinsky is the current CEO of Suturegard.
Is Suturegard a funded company?
Suturegard is a funded company, having raised a total of $580K across 3 funding rounds to date. The company's 1st funding round was a Seed of $550K, raised on Jan 14, 2021.
What does Suturegard do?
Suturegard was founded in 2015 in Portland, United States, within the medical devices sector. Devices for wound closure are produced, including SutureGard, which pre-stretches skin prior to closure or serves as an alternative to skin flaps, grafts, or secondary intention healing. HemiGard is offered as an adhesive retention suture device designed for fragile skin wounds to prevent tearing during closure. Operations focus on manufacturing these products for surgical applications.
Who are the top competitors of Suturegard?
Suturegard's top competitors include Adhezion Biomedical, BRIJ Medical and Inno Therapy.